Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by langostaon Feb 25, 2018 2:01pm
98 Views
Post# 27617417

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:SPIE. Photonics Europe - April 2018

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:SPIE. Photonics Europe - April 2018Bluebomber says: If we all deal with the real issues, this board will be better for it. 

Yes, let's talk about the real issues. We can start with the,

" STATEMENT OF ALLEGATIONS" as put out by the OSC. Just take a good read.

There are some on here who will blame everything or anything from Health Canada to Mother Theresa for the current status of this company. The one thing/person they will not blame is R. Dumoulin-White. The company President, CEO, and Chairman of the Board.. This guy is the Boss, he's the Skipper, the ultimate company authority. Nothing regarding this company is released in NR's until it has passed over his desk. He may not compose all of the NR's but his John Henry is on the final page.
Go over the NR's back to the start of 2014. there are a number which demonstrate significant Fwd Lkng BS screwups. 
Oct 5/16 ITA update had to be filed with HC. They had several meetings with HC to determine requirements for ITA and they still screwed it up.
 July 29/16 ITA filing with HC, on approval commence patients for phase 1b. (Yeah right).
Jan 14/16 Debut of TLC2000 in Las Vegas. State of the art device, no other like it. Dedicated marketing program. (How well did that turn out).
Nov 26/15 Launch in the USA of the TLC 2000. A Watershed Moment for the company. Significant revenue increase in 2016. (Oh Yeah).
Sept 18/15 Original submission to HC for ITA approval.

I could go on listing more issues but I'll leave it at that. 
I don't believe there is anyone on here that so far has issues with the science, from medical neophytes to the more knowledgeable, (I belong in the first category) I have, in the past, like many here, been involved in leadership positions and have always felt that this combination of one person being the singular triumvirate is, in many cases destined for disaster. 

I'll get back to my immature name calling in my next post.         
Bullboard Posts